|
|
Autism Research Institute
Autism Research Review International
1987 to 2004, Volumes 1 to 18
W
Waardenburg, Shah syndrome, 2001, Vol. 15(2) pp. 6
Wagner, Heidi, 1995, Vol. 09(1) pp. 7
Wagner, Karen Dineen, 1996, Vol. 10(2) pp. 4
Wagstaff, Leslie, 1994, Vol. 08(1) pp. 7
Wahlstrom, Jan, 1987, Vol. 01(1) pp. 6
Wakefield, Andrew J.
Congressional testimony on MMR and metabolic and brain dysfunction, 2000, Vol. 14(2) pp. 7
on gut-brain connection, 2002, Vol. 16(3) pp. 2
Help Andy Fund, 2004, Vol. 18(1) pp. 9
Legal Aid Board troubles, 2004, Vol. 18(1) pp. 1; 2004, Vol. 18(1) pp. 9; 2004, Vol. 18(2) pp. 3.
on MMR and autistic behaviors, 1998, Vol. 12(1) pp. 1; 1999, Vol. 13(3) pp. 1; 2000, Vol. 14(2) pp. 7; 2001, Vol. 15(3) pp. 2; 2002, Vol. 16(1) pp. 6.
on MMR and Crohn's disease, 1996, Vol. 10(4) pp. 6; 1998, Vol. 12(1) pp. 1.
on MMR and gastrointestinal symptoms, 1998, Vol. 12(1) pp. 1; 2000, Vol. 14(2) pp. 7; 2000, Vol. 14(4) pp. 1.
on MMR and inflammatory bowel disease, 2000, Vol. 14(4) pp. 1; 2001, Vol. 15(1) pp. 1; 2001, Vol. 15(4) pp. 2; 2002, Vol. 16(1) pp. 1; 2002, Vol. 16(2) pp. 1; 2003, Vol. 17(2) pp. 1; 2003, Vol. 17(4) pp. 1; 2004, Vol. 18(2) pp. 3; 2004, Vol. 18(3) pp. 7.
and Royal Free Hospital in London, 2001, Vol. 15(4) pp. 1
vaccine related autism, 1998, Vol. 12(4) pp. 1
Wakefield, John
Walberg Ekvall, Shirley, 1993, Vol. 07(2) pp. 2
Waldhoer, M., 1995, Vol. 09(4) pp. 2
Walker, Frank, 1990, Vol. 04(1) pp. 1–2
Walker-Smith, John, 2004, Vol. 18(1) pp. 9
Walsh, Michele E., 1987, Vol. 01(2) pp. 5
Walsh, William J., 2001, Vol. 15(2) pp. 4; 2002, Vol. 16(2) pp. 3; 2002, Vol. 16(3) pp. 1; 2004, Vol. 18(4) pp. 7.
Walters, Anne, 1990, Vol. 04(2) pp. 1
Waring, R. H., 1994, Vol. 08(1) pp. 4
Waring, Rosemary, 2003, Vol. 17(2) pp. 7
Warner, Jack
Warner, John, 1989, Vol. 03(1) pp. 4
Warner, John O., 2004, Vol. 18(3) pp. 2
Warren, Reed, P., 1987, Vol. 01(2) pp. 2; 1993, Vol. 07(4) pp. 1; 1998, Vol. 12(1) pp. 7.
Washington, 2004, Vol. 18(4) pp. 3
Wassink, Thomas H., 2001, Vol. 15(2) pp. 2
Waters, Andy, 2001, Vol. 15(4) pp. 1; 2004, Vol. 18(4) pp. 2.
Waters and Kraus, 2001, Vol. 15(1) pp. 2; 2001, Vol. 15(3) pp. 9; 2001, Vol. 15(4) pp. 1.
Watkins, John M., 1989, Vol. 03(4) pp. 4
Watters, Robert, 1989, Vol. 03(1) pp. 7
Watters, Wilhelmina, 1989, Vol. 03(1) pp. 7
Watts, Emily, 1991, Vol. 05(4) pp. 5
Waxman, Henry (Representative, CA), 1992, Vol. 06(2) pp. 3; 1992, Vol. 06(3) pp. 2; 1994, Vol. 08(3) pp. 7.
Web Trek Connect, 2001, Vol. 15(3) pp. 5
Weber, Robert, 1993, Vol. 07(1) pp. 5
websites. See also databases
on anesthesia, 2000, Vol. 14(4) pp. 7
AOL DisAbilities Forum, 1994, Vol. 08(3) pp. 6
ARI, 1999, Vol. 13(4) pp. 2; 2000, Vol. 14(4) pp. 3; 2002, Vol. 16(1) pp. 3; 2004, Vol. 18(3) pp. 3.
Autism Network for Dietary Intervention (ANDI), 2002, Vol. 16(3) pp. 7
AutismIsTreatable, 2003, Vol. 17(4) pp. 1
Billy Tommey's secretin success story, 1999, Vol. 13(3) pp. 2
Bose (sound-cancelling headset), 2002, Vol. 16(3) pp. 7
Celiac List, 1996, Vol. 10(3) pp. 7
Donna Williams' music CD, 1999, Vol. 13(2) pp. 7
on drug interactions, 1996, Vol. 10(3) pp. 4
for EDS neurofeedback, 1996, Vol. 10(4) pp. 6
FDA (Food and Drug Administration), 2003, Vol. 17(2) pp. 1
fenfluramine heart damage compensation claims, 2002, Vol. 16(4) pp. 2
on gluten- and casein-free diet, 2002, Vol. 16(1) pp. 3
Homeowners Against Deficient Dwellings, 2004, Vol. 18(4) pp. 7
Institutes of Medcine's position on vaccines, 2001, Vol. 15(3) pp. 1
International Rett Syndrome Association, 1999, Vol. 13(1) pp. 6
Jang, Miriam, 2003, Vol. 17(1) pp. 7
Jonathan Wright, 1998, Vol. 12(4) pp. 7
of Linda Linday, M. D., 1999, Vol. 13(2) pp. 2
on marijuana, 2003, Vol. 17(1) pp. 3
Megson, Mary A., 2000, Vol. 14(1) pp. 6
nomercury.org, 2004, Vol. 18(4) pp. 3
Prader-Willi Syndrome Association, 2001, Vol. 15(3) pp. 6
pre-vaccination screening, 2003, Vol. 17(2) pp. 5
Repligen's secretin site, 1999, Vol. 13(1) pp. 3; 2002, Vol. 16(2) pp. 2; 2002, Vol. 16(4) pp. 4.
Schafer Autism Report, 2003, Vol. 17(3) pp. 3
sign language lexicon, 2001, Vol. 15(2) pp. 7
Think Twice, 2003, Vol. 17(2) pp. 4
vaccinations requirements in state schools, 2003, Vol. 17(2) pp. 4
Voices of Safety, 2001, Vol. 15(2) pp. 6; 2003, Vol. 17(2) pp. 5.
websites headset, 2002, Vol. 16(3) pp. 7
Webster, Alec, 2002, Vol. 16(3) pp. 5
Webster, Christopher D., 1991, Vol. 05(1) pp. 7
weight gain, 1997, Vol. 11(3) pp. 2; 1998, Vol. 12(3) pp. 1; 2000, Vol. 14(3) pp. 4; 2001, Vol. 15(4) pp. 5; 2002, Vol. 16(2) pp. 6; 2002, Vol. 16(4) pp. 6; 2004, Vol. 18(2) pp. 2.
Weizman, R., 1987, Vol. 01(2) pp. 6
Welch, Elaine, 1989, Vol. 03(4) pp. 7
Welch, Martha, 1987, Vol. 01(3) pp. 3; 1988, Vol. 02(4) pp. 3; 1989, Vol. 03(3) pp. 3.
Weldon, Dave (Representative, FL)
Wellbutrin (bupropion), 2004, Vol. 18(3) pp. 6
Wernicke's area, 2004, Vol. 18(3) pp. 2
Werry, John, 1995, Vol. 09(4) pp. 4
West syndrome, 1994, Vol. 08(1) pp. 1–2
West Virginia autism registry, 2004, Vol. 18(1) pp. 5
Westphal, G. A., 2003, Vol. 17(1) pp. 2
Westport, Connecticut, 1997, Vol. 11(4) pp. 2
Westview School (Houston, TX), 1999, Vol. 13(4) pp. 6
Wetherby, Amy, 1990, Vol. 04(3) pp. 6
Wheelock, Julia B., 1996, Vol. 10(3) pp. 6
Wheelwright, Sally, 2003, Vol. 17(2) pp. 5
Whipple, Tracy D., 1996, Vol. 10(3) pp. 6
Whistler, Walter, 1991, Vol. 05(1) pp. 2
White, Mary Jane, 1995, Vol. 09(3) pp. 7
White, Tonya, 2001, Vol. 15(1) pp. 5
White, William J., 1987, Vol. 01(2) pp. 5
Whiteley, Paul, 1999, Vol. 13(2) pp. 6
Wilder, B. J., 2001, Vol. 15(4) pp. 4
Willatts, P., 1999, Vol. 13(1) pp. 7
Willemsen, Rob, 1995, Vol. 09(3) pp. 1
Willemsen-Swinkels, Sophie H. N., 1996, Vol. 10(1) pp. 4; 1996, Vol. 10(3) pp. 6.
Williams, Don E., 1995, Vol. 09(1) pp. 5; 1995, Vol. 09(4) pp. 2; 1996, Vol. 10(4) pp. 2.
Williams, Donna, 1994, Vol. 08(1) pp. 6; 1995, Vol. 09(4) pp. 6; 1999, Vol. 13(2) pp. 7.
Williams, J. H. G., 2001, Vol. 15(3) pp. 4
Williams, Michael, 2001, Vol. 15(3) pp. 2
Williams, P. Gail, 1998, Vol. 12(1) pp. 5
Williams, Robert, 1994, Vol. 08(4) pp. 1
Williams, Roger J., 2001, Vol. 15(1) pp. 3
Williams Syndrome, 1987, Vol. 01(4) pp. 4; 1994, Vol. 08(2) pp. 4; 1997, Vol. 11(1) pp. 7; 2001, Vol. 15(4) pp. 4.
Wilson, D. R., 2002, Vol. 16(4) pp. 6
Wilson, Deirdre, 1990, Vol. 04(2) pp. 2
Wilson, John, Jr., 1992, Vol. 06(4) pp. 4
Wilson, John and Sheryl, 1996, Vol. 10(4) pp. 6
Wilson, Mike, 1995, Vol. 09(3) pp. 2
Wilson, Nevin, 1999, Vol. 13(3) pp. 4
Wilson, Pete (Governor), 1995, Vol. 09(2) pp. 3
Wimpory, Dawn, 1991, Vol. 05(3) pp. 5; 1992, Vol. 06(1) pp. 5.
Wing, Lorna, 1988, Vol. 02(4) pp. 1; 1989, Vol. 03(1) pp. 6.
Winnergard, I., 1988, Vol. 02(1) pp. 2
Winrow, Christopher J., 2003, Vol. 17(1) pp. 6
Winterling, Vincent, 1987, Vol. 01(3) pp. 5; 1988, Vol. 02(3) pp. 2.
withdrawal symptoms, 1997, Vol. 11(2) pp. 7; 1998, Vol. 12(2) pp. 6; 2003, Vol. 17(2) pp. 4.
Witkin, S.S., 1989, Vol. 03(1) pp. 6
WNT2 gene, 2001, Vol. 15(2) pp. 2
Wolbert, Randall, 1994, Vol. 08(1) pp. 6
Wolf, Lucille, 1991, Vol. 05(3) pp. 7
Wolf-Schein, Enid, 1987, Vol. 01(1) pp. 6; 1988, Vol. 02(2) pp. 5.
Wolff, Aileen, 1992, Vol. 06(1) pp. 7
Wolfson, Ben, 1994, Vol. 08(1) pp. 7
Wolkind, S. N., 1992, Vol. 06(1) pp. 4
Wolpert, Gloria, 1991, Vol. 05(3) pp. 6
Wood, Carolyn, 1989, Vol. 03(4) pp. 7
Woodhouse, Charles E., 1991, Vol. 05(4) pp. 6
Woods, Douglas W., 2003, Vol. 17(2) pp. 5
Woodward, K. G., 1996, Vol. 10(3) pp. 2
Wooltorton, Eric, 2002, Vol. 16(4) pp. 7
work issues, 1987, Vol. 01(1) pp. 5
World Health Organization (WHO), 2003, Vol. 17(2) pp. 7
Woyro, Richard, 1989, Vol. 03(1) pp. 1
Wright, Carrie S., 2002, Vol. 16(2) pp. 5
Wright, Harry, 1987, Vol. 01(1) pp. 6–7
Wright, Jonathan, 1992, Vol. 06(2) pp. 3; 1993, Vol. 07(4) pp. 7; 1998, Vol. 12(4) pp. 7.
Wurtman, Richard, 1994, Vol. 08(3) pp. 2
Wyden, Ron (Representative, OR), 1992, Vol. 06(2) pp. 3; 1993, Vol. 07(2) pp. 1; 1997, Vol. 11(1) pp. 3.
Wyeth Laboratories, 2003, Vol. 17(3) pp. 2
© copyright 2005, 2006 Autism Research Institute
|
|
